Greenwood E, Nimmo S, PATERSON H, Homer N, Foo I
Perioper Med (Lond). 2019; 8:1.
PMID: 30858969
PMC: 6390549.
DOI: 10.1186/s13741-019-0112-4.
Hsu Y, Somma J, Newman M, Mathew J
J Cardiothorac Vasc Anesth. 2011; 25(6):931-6.
PMID: 21616681
PMC: 3203309.
DOI: 10.1053/j.jvca.2011.03.008.
McCarthy G, Megalla S, Habib A
Drugs. 2010; 70(9):1149-63.
PMID: 20518581
DOI: 10.2165/10898560-000000000-00000.
Mathew J, Mackensen G, Phillips-Bute B, Grocott H, Glower D, Laskowitz D
Stroke. 2009; 40(3):880-7.
PMID: 19164788
PMC: 3718309.
DOI: 10.1161/STROKEAHA.108.531236.
Kwa A, Sprung J, Van Guilder M, Jelliffe R
Ther Drug Monit. 2008; 30(3):379-89.
PMID: 18520611
PMC: 2724678.
DOI: 10.1097/FTD.0b013e3181778fa3.
Pharmacokinetics of local anaesthetics in infants and children.
Mazoit J, Dalens B
Clin Pharmacokinet. 2004; 43(1):17-32.
PMID: 14715049
DOI: 10.2165/00003088-200443010-00002.
Pharmacokinetic based adjustment of lidocaine antiarrhythmic schedule.
Voicu V, Mircioiu C, Jinga M, Ionescu M, Burcea X, Ionescu D
Eur J Drug Metab Pharmacokinet. 1994; 19(1):33-6.
PMID: 7957449
DOI: 10.1007/BF03188820.
Lignocaine and indocyanine green kinetics in patients following myocardial infarction.
Bax N, Tucker G, Woods H
Br J Clin Pharmacol. 1980; 10(4):353-61.
PMID: 7448106
PMC: 1430088.
DOI: 10.1111/j.1365-2125.1980.tb01771.x.
Pharmacokinetics of lidocaine and its deethylated metabolite: dose and time dependency studies in man.
Bennett P, Aarons L, Bending M, Steiner J, Rowland M
J Pharmacokinet Biopharm. 1982; 10(3):265-81.
PMID: 7175699
DOI: 10.1007/BF01059261.
On the role of alpha 1-acid glycoprotein in lignocaine accumulation following myocardial infarction.
Barchowsky A, SHAND D, Stargel W, Wagner G, Routledge P
Br J Clin Pharmacol. 1982; 13(3):411-5.
PMID: 7059443
PMC: 1402123.
DOI: 10.1111/j.1365-2125.1982.tb01394.x.
Therapeutic drug monitoring of antiarrhythmic agents.
Brown J, SHAND D
Clin Pharmacokinet. 1982; 7(2):125-48.
PMID: 7039925
DOI: 10.2165/00003088-198207020-00003.
Time-dependent kinetics of lignocaine in the isolated perfused rat liver.
Lennard M, Tucker G, Woods H
J Pharmacokinet Biopharm. 1983; 11(2):165-82.
PMID: 6886972
DOI: 10.1007/BF01061847.
Prolonged variability in plasma protein binding of disopyramide after acute myocardial infarction.
David B, Ilett K, Whitford E, STENHOUSE N
Br J Clin Pharmacol. 1983; 15(4):435-41.
PMID: 6849779
PMC: 1427808.
DOI: 10.1111/j.1365-2125.1983.tb01527.x.
alpha 1-Acid glycoprotein and plasma lidocaine binding.
SHAND D
Clin Pharmacokinet. 1984; 9 Suppl 1:27-31.
PMID: 6705424
DOI: 10.2165/00003088-198400091-00004.
Pitfalls and perils of intravenous lidocaine.
Bryant C, Hoffman J, Nichter L
West J Med. 1983; 139(4):528-30.
PMID: 6649601
PMC: 1021575.
Hormonal and haemodynamic responses to upper abdominal surgery during isoflurane and balanced anaesthesia.
Gelman S, Rivas J, Erdemir H, Oparil S, Proctor J, MacKrell T
Can Anaesth Soc J. 1984; 31(5):509-16.
PMID: 6498567
DOI: 10.1007/BF03009535.
Rapid prediction of individual dosage requirements for lignocaine.
Vozeh S, Berger M, Wenk M, Ritz R, Follath F
Clin Pharmacokinet. 1984; 9(4):354-63.
PMID: 6467768
DOI: 10.2165/00003088-198409040-00005.
The appropriate dosage regime for the transition from intravenous lignocaine to oral tocainide after acute myocardial infarction.
Upward J, Holt D, Emery P, Akhras F, Jackson G
Eur J Clin Pharmacol. 1983; 25(5):589-94.
PMID: 6420162
DOI: 10.1007/BF00542344.
Pharmacokinetic and pharmacodynamic considerations in drug therapy of cardiac emergencies.
Pentel P, Benowitz N
Clin Pharmacokinet. 1984; 9(4):273-308.
PMID: 6380870
DOI: 10.2165/00003088-198409040-00001.
Antiarrhythmic drugs.
Hillis W, Whiting B
Br Med J (Clin Res Ed). 1983; 286(6374):1332-6.
PMID: 6132656
PMC: 1547633.
DOI: 10.1136/bmj.286.6374.1332.